56 related articles for article (PubMed ID: 1653009)
1. Two DNA-bound E2 dimers are required for strong transcriptional activation and for cooperation with cellular factors in most cells.
Gauthier JM; Dostatni N; Lusky M; Yaniv M
New Biol; 1991 May; 3(5):498-509. PubMed ID: 1653009
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors.
Kyo S; Tam A; Laimins LA
Virology; 1995 Aug; 211(1):184-97. PubMed ID: 7645210
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.
Cripe TP; Alderborn A; Anderson RD; Parkkinen S; Bergman P; Haugen TH; Pettersson U; Turek LP
New Biol; 1990 May; 2(5):450-63. PubMed ID: 1963084
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of hormone response of human papillomavirus type 16 expression and increased DNA-protein binding by consensus mutations of viral glucocorticoid response elements.
Khare S; Kumar KU; Tang SC; Pater MM; Pater A
J Med Virol; 1996 Nov; 50(3):254-62. PubMed ID: 8923291
[TBL] [Abstract][Full Text] [Related]
5. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
6. A new cellular factor recognizes E2 binding sites of papillomaviruses which mediate transcriptional repression by E2.
Boeckle S; Pfister H; Steger G
Virology; 2002 Feb; 293(1):103-17. PubMed ID: 11853404
[TBL] [Abstract][Full Text] [Related]
7. Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.
Fujii T; Austin D; Guo D; Srimatkandada S; Wang T; Kubushiro K; Masumoto N; Tsukazaki K; Nozawa S; Deisseroth AB
Clin Cancer Res; 2003 Nov; 9(14):5423-8. PubMed ID: 14614029
[TBL] [Abstract][Full Text] [Related]
8. Identification of single amino acids in the human papillomavirus 11 E2 protein critical for the transactivation or replication functions.
Cooper CS; Upmeyer SN; Winokur PL
Virology; 1998 Feb; 241(2):312-22. PubMed ID: 9499806
[TBL] [Abstract][Full Text] [Related]
9. The human papillomavirus type 18 (HPV18) replication protein E1 is a transcriptional activator when interacting with HPV18 E2.
Demeret C; Goyat S; Yaniv M; Thierry F
Virology; 1998 Mar; 242(2):378-86. PubMed ID: 9514974
[TBL] [Abstract][Full Text] [Related]
10. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells.
Desaintes C; Goyat S; Garbay S; Yaniv M; Thierry F
Oncogene; 1999 Aug; 18(32):4538-45. PubMed ID: 10467398
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional control and cell type specificity of HPV gene expression.
Bernard HU; Apt D
Arch Dermatol; 1994 Feb; 130(2):210-5. PubMed ID: 8304760
[TBL] [Abstract][Full Text] [Related]
12. The bovine papillomavirus E2 transactivator is stimulated by the E1 initiator through the E2 activation domain.
Parker LM; Harris S; Gossen M; Botchan MR
Virology; 2000 May; 270(2):430-43. PubMed ID: 10793002
[TBL] [Abstract][Full Text] [Related]
13. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
[TBL] [Abstract][Full Text] [Related]
14. The E1 helicase of human papillomavirus type 11 binds to the origin of replication with low sequence specificity.
Dixon EP; Pahel GL; Rocque WJ; Barnes JA; Lobe DC; Hanlon MH; Alexander KA; Chao SF; Lindley K; Phelps WC
Virology; 2000 May; 270(2):345-57. PubMed ID: 10792994
[TBL] [Abstract][Full Text] [Related]
15. DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins.
Hines CS; Meghoo C; Shetty S; Biburger M; Brenowitz M; Hegde RS
J Mol Biol; 1998 Mar; 276(4):809-18. PubMed ID: 9500925
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of the papilloma virus E2 trans-activator in Saccharomyces cerevisiae.
Lambert PF; Dostatni N; McBride AA; Yaniv M; Howley PM; Arcangioli B
Genes Dev; 1989 Jan; 3(1):38-48. PubMed ID: 2540059
[TBL] [Abstract][Full Text] [Related]
17. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones.
Gloss B; Bernard HU; Seedorf K; Klock G
EMBO J; 1987 Dec; 6(12):3735-43. PubMed ID: 2828035
[TBL] [Abstract][Full Text] [Related]
18. Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distance.
Thierry F; Dostatni N; Arnos F; Yaniv M
Mol Cell Biol; 1990 Aug; 10(8):4431-7. PubMed ID: 2164642
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis of the human papillomavirus type 16-E2 transactivator with antipeptide antibodies reveals a high mobility region linking the transactivation and the DNA-binding domains.
Gauthier JM; Dillner J; Yaniv M
Nucleic Acids Res; 1991 Dec; 19(25):7073-9. PubMed ID: 1662805
[TBL] [Abstract][Full Text] [Related]
20. Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains.
Giri I; Yaniv M
EMBO J; 1988 Sep; 7(9):2823-9. PubMed ID: 2846285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
